RecruitingNot ApplicableNCT03916809

EMST in Patients Undergoing CRT for HNCA

Impact of Expiratory Muscle Strength Training (EMST) on Swallowing Function in Persons Undergoing Radiotherapy With or Without Chemotherapy (CRT) for Cancers of the Head and Neck (HNCA)


Sponsor

University of Wisconsin, Milwaukee

Enrollment

30 participants

Start Date

Jul 12, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether breathing exercises using a pressure threshold device (EMST150) during chemoradiation for head and neck cancer can prevent swallowing difficulties — a common and serious side effect of this treatment. **You may be eligible if...** - You have a new diagnosis of cancer in the mouth, throat, or voice box (larynx) - Your planned treatment is radiation therapy with or without chemotherapy (not primary surgery) - You are 18 or older and able to use the device (can hold it in your mouth and form a lip seal) **You may NOT be eligible if...** - Your primary treatment is surgery to the head and neck - You have a progressive neurological condition affecting muscle strength (e.g., ALS or Parkinson's) - You have swallowing difficulties unrelated to your cancer - You have had prior head and neck radiation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREMST

Expiratory muscle strength training (EMST) is an exercise program designed to strengthen the muscles of expiration by increasing expiratory load during breathing exercises using either resistive or pressure threshold devices. The EMST150 is a commercially-available device considered non-significant risk (NSR). The EMST150 device will be used for this study.


Locations(2)

University of Wisconsin Milwaukee

Milwaukee, Wisconsin, United States

Froedtert Hospital

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03916809


Related Trials